MarketScreener Strategies Johnson & Johnson Deutsche Boerse AG

Equities

Delayed Deutsche Boerse AG Other stock markets 02:10:06 2024-06-21 EDT			5-day change	1st Jan Change
13.1 ^EUR	+1.55%		+1.55%	-4.38%

06-20	Johnson & Johnson Files Application With US FDA Seeking Approval of Tremfya to Treat Crohn's Disease	MT
06-20	Johnson & Johnson Submits Application to U.S. FDA Seek Approval of TREMFYA®? for the Treatment of Moderate to Severe Active Crohn's Disease	CI

No results for this search

Joseph Wolk, CFO of J&J: End of patent for its flagship drug

January 23, 2024 at 12:30 pm